Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
European Urology|July 2, 2018
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate CancerStephanie Guillaumier, Max Peters, Manit Arya, et al.
The Journal of Urology|July 24, 2019
Comparison of Transrectal Ultrasound Biopsy to Transperineal Template Mapping Biopsies Stratified by Multiparametric Magnetic Resonance Imaging Score in the PROMIS TrialCatherine E Lovegrove, Saiful Miah, Ahmed El-Shater Bosaily, et al.
Journal of Endourology|April 8, 2020
An Exploratory Study of Dose Escalation vs Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate CancerPhilipp M Huber, Naveed Afzal, Manit Arya, et al.
The Journal of Urology|January 14, 2020
Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused UltrasoundPhilipp M Huber, Naveed Afzal, Manit Arya, et al.
BJU International|January 24, 2020
Evaluation of functional outcomes after a second focal high-intensity focused ultrasonography (HIFU) procedure in men with primary localized, non-metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registryCatherine E Lovegrove, Max Peters, Stephanie Guillaumier, et al.
BMJ Open|November 19, 2021
Metastatic prostate cancer men's attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment studyMartin John Connor, Mesfin G Genie, Michael Gonzalez, et al.
Journal of Medical Economics|September 1, 2023
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysisDeepika Reddy, Marieke van Son, Max Peters, et al.
Health Technology Assessment (Winchester, England)|September 29, 2018
Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCTFreddie C Hamdy, Daisy Elliott, Steffi le Conte, et al.
The Journal of Urology|April 4, 2023
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year ExperienceDavid Habashy, Deepika Reddy, Max Peters, et al.
European Urology Oncology|July 7, 2024
Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER StudyMartin J Connor, Mesfin Genie, Tim Dudderidge, et al.
Pageof 6